NSE BSE
gennex laboratories ltd. stock

GENNEX LABORATORIES LTD. Share Price

- - (%)
- NSE: GENNEX

GENNEX LABORATORIES LTD. Share Price Update

As of the latest trading session, GENNEX LABORATORIES LTD. share price is currently at 14.2, which is up by 0.50 from its previous closing. Today, the stock has fluctuated between 13.25 and 14.30. Over the past year, GENNEX LABORATORIES LTD. has achieved a return of 114.82 %. In the last month alone, the return has been -9.61 %. Read More...

GENNEX LABORATORIES LTD. Performance

Day Range

Low13.25 High14.30
14.20

52 Week Range

Low 6.15 High 21.89
14.20

GENNEX LABORATORIES LTD. Share Price

531739

GENNEX

img img img img
No Data Available

Open Price

13.25

Prev. Close

13.70

Volume (Shares)

853406.00

Total traded value

118.83

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

GENNEX LABORATORIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 255.87
PE Ratio (TTM) 27.31
Book Value / Share 7.50
Beta 0.32
ROE 7.41%
EPS (TTM) 0.52
Dividend Yield 0.00%
Net Profit Qtr (Cr) 3.93

GENNEX LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 21.33
Operating Expense 18.69
Net Profit 3.93
Net Profit Margin (%) 18.42
Earnings Per Share (EPS) 0.24
EBITDA 5.06
Effective Tax Rate (%) 14.75
Particulars DEC 2023 (Values in Cr)
Revenue 17.08
Operating Expense 16.16
Net Profit 2.64
Net Profit Margin (%) 15.45
Earnings Per Share (EPS) 0.15
EBITDA 3.68
Effective Tax Rate (%) 16.45
Particulars SEP 2023 (Values in Cr)
Revenue 14.24
Operating Expense 10.76
Net Profit 2.66
Net Profit Margin (%) 18.67
Earnings Per Share (EPS) 0.15
EBITDA 4.03
Effective Tax Rate (%) 25.07
Particulars JUN 2023 (Values in Cr)
Revenue 14.14
Operating Expense 10.73
Net Profit 2.57
Net Profit Margin (%) 18.17
Earnings Per Share (EPS) 0.15
EBITDA 3.95
Effective Tax Rate (%) 25.21
Particulars MAR 2023 (Values in Cr)
Revenue 18.15
Operating Expense 17.59
Net Profit 1.67
Net Profit Margin (%) 9.20
Earnings Per Share (EPS) 0.10
EBITDA 2.87
Effective Tax Rate (%) 22.22
Particulars MAR 2024 (Values in Cr)
Revenue 66.80
Operating Expense 56.34
Net Profit 11.80
Net Profit Margin (%) 17.66
Earnings Per Share (EPS) 0.70
EBITDA 16.72
Effective Tax Rate (%) 20.06
Particulars MAR 2023 (Values in Cr)
Revenue 65.10
Operating Expense 62.48
Net Profit 4.56
Net Profit Margin (%) 7.00
Earnings Per Share (EPS) 0.26
EBITDA 7.98
Effective Tax Rate (%) 24.12
Particulars MAR 2022 (Values in Cr)
Revenue 61.21
Operating Expense 57.50
Net Profit 3.92
Net Profit Margin (%) 6.40
Earnings Per Share (EPS) 0.33
EBITDA 6.76
Effective Tax Rate (%) 22.98
Particulars MAR 2021 (Values in Cr)
Revenue 59.65
Operating Expense 54.74
Net Profit 4.04
Net Profit Margin (%) 6.77
Earnings Per Share (EPS) 0.32
EBITDA 6.68
Effective Tax Rate (%) 20.15
Particulars MAR 2020 (Values in Cr)
Revenue 55.62
Operating Expense 54.13
Net Profit 1.86
Net Profit Margin (%) 3.34
Earnings Per Share (EPS) 0.15
EBITDA 4.31
Effective Tax Rate (%) 27.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 4.39
ROE % 7.41
ROCE % 10.69
Total Debt to Total Equity 0.09
EBITDA Margin 11.20
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.48
ROE % 9.35
ROCE % 11.78
Total Debt to Total Equity 0.21
EBITDA Margin 10.36
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.15
ROE % 10.67
ROCE % 13.16
Total Debt to Total Equity 0.16
EBITDA Margin 10.49
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2.83
ROE % 5.33
ROCE % 8.31
Total Debt to Total Equity 0.14
EBITDA Margin 7.17
Particulars MAR 2019 (Values in Cr)
Book Value / Share 2.69
ROE % 6.75
ROCE % 10.48
Total Debt to Total Equity 0.11
EBITDA Margin 8.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 15.06
Total Assets 132.31
Total Liabilities 132.31
Total Equity 86.51
Share Outstanding 180192662
Price to Book Ratio 1.28
Return on Assets (%) 3.71
Return on Capital (%) 5.62
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.31
Total Assets 68.02
Total Liabilities 68.02
Total Equity 43.81
Share Outstanding 126503000
Price to Book Ratio 2.16
Return on Assets (%) 5.76
Return on Capital (%) 7.27
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.06
Total Assets 58.90
Total Liabilities 58.90
Total Equity 39.70
Share Outstanding 126503000
Price to Book Ratio 1.24
Return on Assets (%) 6.85
Return on Capital (%) 8.58
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 56.94
Total Liabilities 56.94
Total Equity 35.67
Share Outstanding 126503000
Price to Book Ratio 0.66
Return on Assets (%) 3.25
Return on Capital (%) 4.57
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 3.14
Total Assets 51.73
Total Liabilities 51.73
Total Equity 33.81
Share Outstanding 126503000
Price to Book Ratio 1.16
Return on Assets (%) 4.29
Return on Capital (%) 5.79
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.45
Total Assets 96.22
Total Liabilities 96.22
Total Equity 79.01
Share Outstanding 180192661
Price to Book Ratio 1.28
Return on Assets (%) 4.73
Return on Capital (%) 5.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.31
Total Assets 68.20
Total Liabilities 68.20
Total Equity 43.99
Share Outstanding 126503000
Price to Book Ratio 2.16
Return on Assets (%) 5.75
Return on Capital (%) 7.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.06
Total Assets 59.08
Total Liabilities 59.08
Total Equity 39.89
Share Outstanding 126503000
Price to Book Ratio 1.24
Return on Assets (%) 6.83
Return on Capital (%) 8.55
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 57.12
Total Liabilities 57.12
Total Equity 35.85
Share Outstanding 126503000
Price to Book Ratio 0.66
Return on Assets (%) 3.24
Return on Capital (%) 4.55
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 3.14
Total Assets 51.91
Total Liabilities 51.91
Total Equity 33.99
Share Outstanding 126503000
Price to Book Ratio 1.16
Return on Assets (%) 4.27
Return on Capital (%) 5.76
Particulars MAR 2023 (Values in Cr)
Net Income 6.37
Cash from Operations 23.67
Cash from Investing -38.32
Cash from Financing 21.03
Net change in Cash 6.38
Free Cash Flow 63.46
Particulars MAR 2022 (Values in Cr)
Net Income 5.27
Cash from Operations 13.01
Cash from Investing -2.46
Cash from Financing -1.83
Net change in Cash 7.61
Free Cash Flow 14.61
Particulars MAR 2021 (Values in Cr)
Net Income 5.06
Cash from Operations 0.09
Cash from Investing -0.02
Cash from Financing 1.61
Net change in Cash 0.15
Free Cash Flow 0.17
Particulars MAR 2020 (Values in Cr)
Net Income 2.54
Cash from Operations -1.66
Cash from Investing -0.21
Cash from Financing -0.34
Net change in Cash -2.23
Free Cash Flow -1.37
Particulars MAR 2019 (Values in Cr)
Net Income 3.02
Cash from Operations 2.22
Cash from Investing -0.99
Cash from Financing 1.24
Net change in Cash 2.12
Free Cash Flow 3.26
Particulars MAR 2023 (Values in Cr)
Net Income 6.01
Cash from Operations -14.45
Cash from Investing -0.76
Cash from Financing 21.35
Net change in Cash 6.13
Free Cash Flow -12.22
Particulars MAR 2022 (Values in Cr)
Net Income 5.27
Cash from Operations 7.74
Cash from Investing -1.26
Cash from Financing 1.86
Net change in Cash 7.24
Free Cash Flow 8.13
Particulars MAR 2021 (Values in Cr)
Net Income 5.06
Cash from Operations 0.09
Cash from Investing -0.02
Cash from Financing 1.61
Net change in Cash 0.15
Free Cash Flow 0.17
Particulars MAR 2020 (Values in Cr)
Net Income 2.54
Cash from Operations -1.66
Cash from Investing -0.21
Cash from Financing -0.34
Net change in Cash -2.23
Free Cash Flow -1.37
Particulars MAR 2019 (Values in Cr)
Net Income 3.02
Cash from Operations 2.22
Cash from Investing -0.99
Cash from Financing 1.24
Net change in Cash 2.12
Free Cash Flow 3.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
GENNEX LABORATORIES LTD. 14.20 24.48 1.89 322.98 6.15 / 21.89
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
GENNEX LABORATORIES LTD. 14.20 27.31 1.89 322.98 6.15 / 21.89
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 14.10
  • 26 Days 15.00
  • 10 Days 14.40
  • 50 Days 15.40
  • 12 Days 14.50
  • 100 Days 16.50
  • 20 Days 14.90
  • 200 Days 9.70
13.94
PIVOT
First Resistance 14.36
Second Resistance 15.03
Third Resistance 15.45
First Support 13.27
Second Support 12.85
Third Support 12.18
RSI 30.85
MACD -0.45
Commodity Channel Index (CCI) -139.45
ADX 42.39
Williams % R -64.02

Over 1 Month

down

-9.61

Over 3 Months

down

-12.18

Over 6 Months

down

-21.28

Over 1 Year

down

114.82

Over 3 Years

down

10.97

Over 5 Years

down

32.25

GENNEX LABORATORIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GENNEX LABORATORIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
81.58
Promoter Holdings
18.41
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Premier Fiscal Services Private Limited Shareholding of Promoter and Promoter Group 3.7538E7 16.5
Jms Mines & Minerals Private Limited Public Shareholding 7900000.0 3.47
Maryada Barter Pvt. Ltd. Public Shareholding 5149540.0 2.26
Vidya Tradecon Private Limited Public Shareholding 5000000.0 2.2
Brij Bhushan Agarwal Public Shareholding 4500000.0 1.98
Sumitra Devi Agarwal Public Shareholding 4500000.0 1.98
Sumita Talwar Public Shareholding 4238401.0 1.86
Hemant Kumar Jain Public Shareholding 4000000.0 1.76
Sanjay Kumar Public Shareholding 3726850.0 1.64
Rajababu Sampatrao Bandela Public Shareholding 3427580.0 1.51
Vab Ventures Limited Shareholding of Promoter and Promoter Group 3432170.0 1.51
Subhash Chand Bhura Trusteeof Anuj Bhura Welfare Trust Shareholding of Promoter and Promoter Group 765450.0 0.34
India Securities Brooking Private Limited Shareholding of Promoter and Promoter Group 60384.0 0.03
Prudential Investment Limited Shareholding of Promoter and Promoter Group 39820.0 0.02
Vinod Baid Shareholding of Promoter and Promoter Group 48000.0 0.02
Vab Capital Advisors Private Limited Shareholding of Promoter and Promoter Group 1500.0 0.0
Gopalakrishnan Muralidharan Tiruvarur Shareholding of Promoter and Promoter Group 150.0 0.0
Arihant Baid Shareholding of Promoter and Promoter Group 150.0 0.0

GENNEX LABORATORIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2009-12-14 10.0 1.0 2009-12-15

Learn More About Stocks

About GENNEX LABORATORIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GENNEX LABORATORIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Gennex Laboratories Ltd?

Answer Field

The share price of Gennex Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 14.20.

What is the Market Cap of Gennex Laboratories Ltd?

Answer Field

The market cap of Gennex Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 3,23.00 Cr. as of now.

What is the 52 Week High and Low of Gennex Laboratories Ltd?

Answer Field

The 52 Week High and Low of Gennex Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 21.89 and ₹ 6.15.

How to Buy Gennex Laboratories Ltd share?

Answer Field

You can trade in Gennex Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gennex Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 114.82%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader